Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying Taur

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
Nature|October 23, 2014
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficileCharlie G Buffie, Vanni Bucci, Richard R Stein, et al.
Blood Advances|July 11, 2019
Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota compositionMatthew J Pianko, Sean M Devlin, Eric R Littmann, et al.
Cell Host & Microbe|June 17, 2023
The TaxUMAP atlas: Efficient display of large clinical microbiome data reveals ecological competition in protection against bacteremiaJonas Schluter, Ana Djukovic, Bradford P Taylor, et al.
Blood|August 15, 2022
Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host diseaseMarina Burgos da Silva, Doris M Ponce, Anqi Dai, et al.
The Journal of Experimental Medicine|May 2, 2012
Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantationRobert R Jenq, Carles Ubeda, Ying Taur, et al.
Nature|November 26, 2020
The gut microbiota is associated with immune cell dynamics in humansJonas Schluter, Jonathan U Peled, Bradford P Taylor, et al.
Blood Cancer Discovery|October 18, 2021
Correction: COVID-19 Infections and Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic CentersMalin Hultcrantz, Joshua Richter, Cara A Rosenbaum, et al.
The Lancet. Microbe|March 5, 2026
Safety, recovery, and pharmacodynamics of CRISPR-Cas therapeutic SNIPR001: a phase 1, randomised, double-blind, first-in-human, dose-escalation studyAnders Østergaard Petersen, Birgitte Damholt, Mette Grove, et al.
Blood|January 21, 2022
Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplantOriana Miltiadous, Nicholas R Waters, Hana Andrlová, et al.
Nature Medicine|June 26, 2020
Determinants of COVID-19 disease severity in patients with cancerElizabeth V Robilotti, N Esther Babady, Peter A Mead, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Nature|October 23, 2014
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficileCharlie G Buffie, Vanni Bucci, Richard R Stein, et al.
Blood Advances|July 11, 2019
Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota compositionMatthew J Pianko, Sean M Devlin, Eric R Littmann, et al.
Cell Host & Microbe|June 17, 2023
The TaxUMAP atlas: Efficient display of large clinical microbiome data reveals ecological competition in protection against bacteremiaJonas Schluter, Ana Djukovic, Bradford P Taylor, et al.
Blood|August 15, 2022
Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host diseaseMarina Burgos da Silva, Doris M Ponce, Anqi Dai, et al.
The Journal of Experimental Medicine|May 2, 2012
Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantationRobert R Jenq, Carles Ubeda, Ying Taur, et al.
Nature|November 26, 2020
The gut microbiota is associated with immune cell dynamics in humansJonas Schluter, Jonathan U Peled, Bradford P Taylor, et al.
Blood Cancer Discovery|October 18, 2021
Correction: COVID-19 Infections and Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic CentersMalin Hultcrantz, Joshua Richter, Cara A Rosenbaum, et al.
The Lancet. Microbe|March 5, 2026
Safety, recovery, and pharmacodynamics of CRISPR-Cas therapeutic SNIPR001: a phase 1, randomised, double-blind, first-in-human, dose-escalation studyAnders Østergaard Petersen, Birgitte Damholt, Mette Grove, et al.
Blood|January 21, 2022
Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplantOriana Miltiadous, Nicholas R Waters, Hana Andrlová, et al.
Nature Medicine|June 26, 2020
Determinants of COVID-19 disease severity in patients with cancerElizabeth V Robilotti, N Esther Babady, Peter A Mead, et al.
Pageof 10